Qian Xia, Zhang Wei, Yang Hua, Zhang Lanjing, Kang Ningling, Lai Jinping
Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, FL, USA.
Department of Ophthalmology, Emory Eye Center, Emory University, Atlanta, GA, USA.
Explor Res Hypothesis Med. 2021 Sep;6(3):110-117. doi: 10.14218/ERHM.2021.00017. Epub 2021 Jun 8.
Yes-associated protein-1 (YAP1) is a potent transcriptional co-activator and functions as an important downstream effector of the Hippo signaling pathway, which is key to regulating cell proliferation, apoptosis, and organ growth. YAP1 has been implicated as an oncogene for various human cancers including gastrointestinal cancers and hepatocellular carcinoma (HCC). YAP1 promotes tumorigenesis and cancer progression by multiple mechanisms, such as by promoting malignant phenotypes, expanding cancer stem cells, and inducing epithelial-mesenchymal transition. YAP1 overexpression or its activated forms are associated with advanced pathological grades and poor prognosis of cancer, and therefore targeting YAP1 may open a fertile avenue for cancer therapy. In this review, we summarize the recent evidence regarding the role of YAP1 in the carcinogenesis of gastrointestinal cancers and HCC.
Yes相关蛋白1(YAP1)是一种强效的转录共激活因子,作为Hippo信号通路的重要下游效应器发挥作用,该通路对于调节细胞增殖、凋亡和器官生长至关重要。YAP1已被认为是包括胃肠道癌和肝细胞癌(HCC)在内的多种人类癌症的致癌基因。YAP1通过多种机制促进肿瘤发生和癌症进展,例如促进恶性表型、扩增癌症干细胞以及诱导上皮-间质转化。YAP1的过表达或其激活形式与癌症的高级别病理分级和不良预后相关,因此靶向YAP1可能为癌症治疗开辟一条富有成效的途径。在本综述中,我们总结了关于YAP1在胃肠道癌和HCC致癌作用方面的最新证据。